insights_auto
Why is GANX down 5.41%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
US$1.05
arrow_downward
-5.41%(-0.060) 1D
US$1.07
arrow_upward
+1.90% (+0.020)bedtimeAfter hours
Closed: ኖቬም 19, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
US$1.12
High
US$1.14
Low
US$1.03
Mkt. cap
46.75 ሚ
Avg. vol.
684.23 ሺ
Volume
30.00
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
Open
US$1.12
High
US$1.14
Low
US$1.03
Mkt. cap
46.75 ሚ
Avg. vol.
684.23 ሺ
Volume
30.00
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
News stories
From web sources and news partners
Quantisnow
·
ከ2 ቀናት በፊት
GANX: Gain Therapeutics Inc. filed SEC Form 8-K: Other Events
Investing.com
·
ከ2 ቀናት በፊት
Gain Therapeutics reports 12-month rexaceract trial results
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com